Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OraSure Technologies Inc (NASDAQ:OSUR)

13.74
Delayed Data
As of Nov 17
 0.00 / 0.00%
Today’s Change
8.21
Today|||52-Week Range
23.01
+56.49%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$833.3M

Company Description

OraSure Technologies, Inc. engages in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices. It operates through the following segments: OraSure and DNAG. The OraSure segment consists of the development, manufacture, and sale of diagnostic products, specimen collection devices, and medical devices. The DNAG segment offers development, manufacture, and sale of oral fluid collection devices that are used to collect, stabilize, and store samples of genetic material for molecular testing. The company was founded by Michael J. Gausling in May 2000 in and is headquartered in Bethlehem, PA.

Contact Information

OraSure Technologies, Inc.
220 East 1st Street
Bethlehem Pennsylvania 18015
P:(610) 882-1820
Investor Relations:
161088218201476

Employees

Shareholders

Individual stakeholders9.21%
Other institutional50.81%
Mutual fund holders48.44%

Top Executives

Douglas A. MichelsPresident, Chief Executive Officer & Director
Ronald H. SpairChief Operating & Financial Officer, Director
Michael ReedChief Science Officer, SVP-Research & Development
Jack E. JerrettSecretary, Senior Vice President & General Counsel
Kathleen G. WeberSenior Vice President & GM-Consumer Products